GRUBER JAMES R. (Chief Financial Officer) reported 1 transaction at ETON PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/14/2026ACC: 0001437749-26-001286
Officer· Chief Financial Officer
Since Apr 2022
+64.22K
Net shares
Net buyer
$35.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
66.51K acquired · 2.29K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.29K
Price / share
$15.47
Trade value
$35.47K
% of position
1.1%
1/14/2026
215.71K→213.42K
Total
Net shares
−2.29K
Net value
-$35.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/14/2026 | F · Tax Withholding | −2.29K | $15.47 | $35.47K | 1.1% | 215.71K | 213.42K |
| Total | −2.29K | -$35.47K | ||||||
Derivative Transactions2
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
40.66K shares
Shares
+40.66K
Strike price
15.47
Held after
254.07K
Exercisable
—
1/12/2026
Restricted Stock Units
Direct
Converts to
Common Stock
25.86K shares
Shares
+25.86K
Strike price
Held after
279.93K
Exercisable
—
1/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock40.66K shares | 1/12/2026 | A · Award | +40.66K | 15.47 | — | 254.07K |
| Restricted Stock Units Direct | Common Stock25.86K shares | 1/12/2026 | A · Award | +25.86K | — | 279.93K |